Change of serum albumin and risk of cardiovascular disease and all-cause mortality: Longitudinal Aging Study Amsterdam

American Journal of Epidemiology

Volumn 164, Issue 10, 2006, Pages 969-977

  Schalk, Bianca W M ^a   Visser, M ^a,b   Bremmer, M A ^a   Penninx, B W J H ^a   Bouter, L M ^a   Deeg, D J H ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Aging; Cardiovascular diseases; Longitudinal studies; Mortality; Serum albumin

Indexed keywords

SERUM ALBUMIN;

CARDIOVASCULAR DISEASE; DATA SET; HEALTH RISK; MORTALITY RISK; PROTEIN;

ADULT; AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; CHI-SQUARE DISTRIBUTION; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; HUMANS; INCIDENCE; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NETHERLANDS; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SERUM ALBUMIN;

AMSTERDAM; BENELUX; EURASIA; EUROPE; NETHERLANDS; NORTH HOLLAND; WESTERN EUROPE;

EID: 33750908440     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwj312     Document Type: Article

References (51)

1. Djousse L, Rothman KJ, Cupples LA, et al. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation 2002;106: 2919-24.
2. Nelson JJ, Liao D, Sharrett AR, et al. Serum albumin level as a predictor of incident coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol 2000;151:468-77.
3. Goldwasser P, Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997;50:693-703.
4. Weijenberg MP, Feskens EJ, Souverijn JH, et al. Serum albumin, coronary heart disease risk, and mortality in an elderly cohort. Epidemiology 1997;8:87-92.
5. Corti MC, Salive ME, Guralnik JM. Serum albumin and physical function as predictors of coronary heart disease mortality and incidence in older persons. J Clin Epidemiol 1996;49:519-26.
6. Corti MC, Guralnik JM, Bilato C. Coronary heart disease risk factors in older persons. Aging (Milano) 1996;8:75-89.
7. Kuller LH, Eichner JE, Orchard TJ, et al. The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial. Am J Epidemiol 1991;134:1266-77.
8. Gillum RF, Makuc DM. Serum albumin, coronary heart disease, and death. Am Heart J 1992;123:507-13.
9. Gillum RF, Ingram DD, Makuc DM. Relation between serum albumin concentration and stroke incidence and death: the NHANES I Epidemiologic Follow-up Study. Am J Epidemiol 1994;140:876-88.
10. Darne B, Ducimetiere P, Guize L. Serum albumin and mortality. (Letter). Lancet 1990;335:350-1.
11. Phillips A, Shaper AG, Whincup PH. Association between serum albumin and mortality from cardiovascular disease, cancer, and other causes. Lancet 1989;2:1434-6.
12. Klonoff-Cohen H, Barrett-Connor EL, Edelstein SL. Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol 1992;45:207-12.
13. Corti MC, Guralnik JM, Salive ME, et al. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA 1994;272:1036-42.
14. Sahyoun NR, Jacques PF, Dallal G, et al. Use of albumin as a predictor of mortality in community dwelling and institutionalized elderly populations. J Clin Epidemiol 1996;49: 981-8.
15. Rozzini R, Barbisoni P, Frisoni GB, et al. Albumin as a predictor of mortality in elderly patients. (Letter). J Clin Epidemiol 1997;50:865-6.
16. Soeters PB, Von Meyenfeldt MF, Meijerink WJHJ, et al. Serum albumin and mortality. (Letter). Lancet 1990;335:348.
17. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepatology 1988;8:385-401.
18. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
19. Bologa RM, Levine DM, Parker TS, et al. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients. Am J Kidney Dis 1998;32:107-14.
20. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 1998;279:1477-82.
21. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342: 836-43.
22. Harris TB, Ferruci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med 1999;106:506-12.
23. Machlin LJ, Bendich A. Free radical tissue damage: protective role of antioxidant nutrients. FASEB J 1987;1:441-5.
24. Barber DA, Harris SR. Oxygen free radicals and antioxidants: a review. Am Pharm 1994;NS34:26-35.
25. De Lorgeril M, Guidollet J, Renaud S. Serum albumin and mortality. (Letter). Lancet 1990;335:349.
26. Halliwell B. Albumin-an important extracellular antioxidant? Biochem Pharmacol 1988;37:569-71.
27. Barradas MA, Mikhailidis DP, Phillips AN, et al. Albumin, haemostasis and cardiovascular disease. (Letter). Fibrinolysis 1991;5:131.
28. Stevens RG, Blumberg BS. Serum albumin and mortality. (Letter). Lancet 1990;335:351.
29. Halliwell B, Gutteridge JM. The antioxidants of human extracellular fluids. Arch Biochem Biophys 1990;280:1-8.
30. Era S, Kuwata K, Imai H, et al. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1995; 1247:12-16.
31. Wayner DD, Burton GW, Ingold KU, et al. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 1985;187:33-7.
32. Zoellner H, Hofler M, Beckmann R, et al. Serum albumin is a specific inhibitor of apoptosis in human endothelial cells. J Cell Sci 1996;109:2571-80.
33. Gosling P, Beevers DG, Goode GE, et al. Serum albumin and mortality. (Letter). Lancet 1990;335:349-50.
34. Ferrari R, Ceconi C, Curello S, et al. Oxygen free radicals and myocardial damage: protective role of thiol-containing agents. Am J Med 1991;91:95S-105S.
35. Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci U S A 1993;90:7915-22.
36. Deeg DJH, Westendorp-de Serière M, eds. Autonomy and well-being in the aging population I: report from the Longitudinal Aging Study Amsterdam 1992-1993. Amsterdam, the Netherlands: VU University Press, 1994.
37. Deeg DJH, Westendorp-de Serière M, eds. Autonomy and well-being in the aging population II: report from the Longitudinal Aging Study Amsterdam 1992-1996. Amsterdam, the Netherlands: VU University Press, 1998.
38. Clase CM, St Pierre MW, Churchill DN. Conversion between bromcresol green- and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 2001;16: 1925-9.
39. Schalk BWM, Visser M, Deeg DJH, et al. Lower levels of serum albumin and total cholesterol and future decline in functional performance in older persons: the Longitudinal Aging Study Amsterdam. Age Ageing 2004;33:266-72.
40. World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death based on recommendations of the Ninth Revision Conference, 1975. Geneva, Switzerland: World Health Organization, 1977.
41. World Health Organization. Manual of the international statistical classification of diseases and related health problems. 10th Revision. Geneva, Switzerland: World Health Organization, 1992.
42. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1977;1:385-401.
43. Beekman AT, Deeg DJ, Van Limbeek J, et al. Criterion validity of the Center for Epidemiologic Studies Depression Scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol Med 1997;27: 231-5.
44. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc 1992;40: 922-35.
45. Grimble R. Serum albumin and mortality. (Letter). Lancet 1990;335:350.
46. Lakatta EG. Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev 2002;7:29-49.
47. Stamler J, Fortmann SP, Levy RI, et al. Primordial prevention of cardiovascular disease risk factors: panel summary. Prev Med 1999;29:S130-5.
48. Kromhout D. Primordial prevention of cardiovascular disease risk in the Netherlands. Prev Med 1999;29:S106-10.
49. DeBusk RF. The role of the health care system in primordial prevention. Prev Med 1999;29:S59-65.
50. Law MR, Morris JK, Wald NJ, et al. Serum albumin and mortality in the BUPA study. British United Provident Association. Int J Epidemiol 1994;23:38-41.
51. Henry JB, Davey FR, Herman CJ, et al, eds. Clinical diagnosis and management by laboratory methods. Philadelphia, PA: W B Saunders Co, 2001.